In this direction, this review presents information on the epigenetic implications of COVID-19 involving ACE2 and the heart, the physiological roles of ACE2, and the current scenario of congenital heart defects and cardiovascular damage in COVID-19 patients, to draw from the above areas for informing future studies that address those questions (Figure 5). The gene discussed is ACE2; the disease is COVID-19.